Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
3 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
10-K
2021 FY
Annual report
25 Feb 22
Current reports
8-K
Regulation FD Disclosure
11 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Regulation FD Disclosure
27 Feb 24
8-K
Encompass Health reports results for fourth quarter 2023
7 Feb 24
8-K
Encompass Health appoints Ted Christie to its board of directors
27 Nov 23
8-K
Encompass Health reports results for third quarter 2023
26 Oct 23
8-K
Regulation FD Disclosure
27 Sep 23
8-K
Encompass Health reports results for second quarter 2023
1 Aug 23
8-K
Departure of Directors or Certain Officers
25 Jul 23
8-K
Regulation FD Disclosure
31 May 23
Registration and prospectus
S-3ASR
Automatic shelf registration
31 Oct 23
424B5
Prospectus supplement for primary offering
1 Oct 20
FWP
Free writing prospectus
30 Sep 20
424B5
Prospectus supplement for primary offering
30 Sep 20
S-3ASR
Automatic shelf registration
21 Sep 20
424B5
Prospectus supplement for primary offering
14 May 20
FWP
Free writing prospectus
13 May 20
POSASR
Automatic shelf registration (post-effective amendment)
12 May 20
424B5
Prospectus supplement for primary offering
12 May 20
424B5
Prospectus supplement for primary offering
11 Sep 19
Proxies
DEF 14A
Definitive proxy
3 Apr 23
DEF 14A
Definitive proxy
4 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Mar 21
DEF 14A
Definitive proxy
26 Mar 21
DEFA14A
Additional proxy soliciting materials
10 Apr 20
DEFA14A
Additional proxy soliciting materials
27 Mar 20
DEF 14A
Definitive proxy
27 Mar 20
DEFA14A
Additional proxy soliciting materials
21 Mar 19
DEF 14A
Definitive proxy
21 Mar 19
DEF 14A
Definitive proxy
23 Mar 18
Other
UPLOAD
Letter from SEC
3 Jul 17
CORRESP
Correspondence with SEC
30 Jun 17
UPLOAD
Letter from SEC
26 Jun 17
EFFECT
Notice of effectiveness
5 Feb 16
CORRESP
Correspondence with SEC
3 Feb 16
UPLOAD
Letter from SEC
1 Feb 16
CORRESP
Correspondence with SEC
29 Jan 16
CERTNYS
Certification of approval for NYSE listing
28 Dec 15
CT ORDER
Confidential treatment order
15 Jun 15
UPLOAD
Letter from SEC
25 Mar 15